Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/447e4d06-ff36-43b2-898e-bd0214238327/

HESTERBIO

Hester Biosciences Limited
Chart
₹1,961.60
Latest Week 2026-06-05
HealthcareDrug Manufacturers - Specialty & GenericLARGE
Snapshot 2026-06-07 · 0.0w · Fresh
0.64
OS Score
27.0%
Value
95.0%
Quality
70.0%
Momentum
8/9
F-Score
0.506
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
27.0%ile
P/E
30.0×
P/S
5.0×
P/B
4.6×
E/P
0.0333
FCF Yield
0.025
EBITDA/EV
0.057
SH Yield
0.004
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
76.00000000
/100 — 1=cheapest
VC2 (Trending Value)
71.00000000
/100
VC3 (Buyback)
67.00000000
/100
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
95.0%ile
ROE
0.154
ROA
0.082
Net Margin
0.167
Op Margin
0.204
GPA
0.370
Current
1.37
F-Score
8/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.069
Earn Growth
1.024
Stability
0.564
lower=better
Accruals
-0.013
lower=better
5yr Consist
No
F-Score of 8/9 indicates strong fundamental improvement across multiple dimensions.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
70.0%ile
6M Return
18.6%
12M Return
6.0%
12-1 Mom
-11.0%
Risk-Adj
-0.27
Vol 252d
40.5%
Vol 60d
71.5%
↑ Expanding
Max DD 12M
-39.7%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -11% signals a downtrend — price is moving against you. Near-term vol (71%) is expanding vs long-term (40%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.64
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 160 peers
Sector Value %ile
50.3%
Sector Quality %ile
91.9%
P/E z-score
-0.19
P/B z-score
-0.18
Sector Avg OS
43.6%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
NATCOPHARM NATCO Pharma Limited 98.0% 88.0% 87.0% 81.0%
LINCOLN Lincoln Pharmaceuticals Limited 97.0% 88.0% 80.0% 81.0%
UNIVPHOTO Universus Photo Imagings Limited 97.0% 86.0% 74.0% 94.0%
VENUSREM Venus Remedies Limited 96.0% 68.0% 94.0% 99.0%
STAR Strides Pharma Science Limited 96.0% 73.0% 91.0% 91.0%
HALEOSLABS Haleos Labs Limited 95.0% 82.0% 77.0% 81.0%
AUROPHARMA Aurobindo Pharma Limited 94.0% 71.0% 84.0% 87.0%
SAGILITY Sagility Limited 93.0% 76.0% 81.0% 76.0%
Factor Interactions
Quality Momentum — Expensive
Strong quality (95th) and momentum (70th) but expensive (27th value). Premium priced — watch for mean reversion.
Quality at a Premium
High quality (95th) but expensive (27th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (71%) significantly exceeds 252-day (40%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
36.4% avg (7 factors)
Quality
C
57.7% avg (7 factors)
Momentum
D
34.4% avg (4 factors)
Risk
C
49.2% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.640—0—
Value %ile0.270—1—
Quality %ile0.950—1—
Momentum %ile0.700—1—
F-Score8.000—1—
Confidence0.939—1—
Volatility0.405—1—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
29.99
Earnings Yield (E/P)
0.0333
Price / Sales
5.02
Price / Book
4.63
Price / Cash Flow
26.02
FCF Yield
2.5%
EBITDA / EV
5.7%
Sales Yield (1/P·S)
0.1787
Shareholder Yield
Div + net buyback / mktcap
0.4%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
15.4%
Return on Assets
8.2%
Net Margin
16.7%
Operating Margin
20.4%
Gross Profit / Assets
Novy-Marx GPA
37.0%
Current Ratio
1.37
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.013
MomentumPrice trend strength over different horizons
6M Return
18.6%
12M Return
6.0%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-11.0%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.27
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
6.9%
Earnings Growth (YoY)
102.4%
Earnings Stability (CV)
Lower = more stable
0.564
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
8
Dividend Yield
0.4%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
76
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
71
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
67
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity